Streetbeat News

Stock Prices

MSOS

TCNNF

Trulieve CEO Kim Rivers anticipates a surge of bills following the SAFER Banking Act vote. The statement was made during a Benzinga conference.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 6:12 pm

MSOS

TCNNF

Trulieve CEO Kim Rivers expressed confidence in a potential rescheduling of cannabis. The information was shared during a Benzinga subscriber event.

Portfolio Pulse from Benzinga Newsdesk

September 27, 2023 | 6:09 pm

CBSH

VLY

ZION

Morgan Stanley analyst Manan Gosalia revised ratings for Valley National Bancorp (VLY), Zions Bancorporation N.A. (ZION), and Commerce Bancshares Inc (CBSH). Gosalia downgraded VLY and ZION to Underweight from Equal-Weight, while upgrading CBSH to Equal-Weight from Underweight. The analyst prefers banks with low loan-to-deposit ratios and less reliance on customer deposits in a higher for longer rate environment.

Portfolio Pulse from Lekha Gupta

September 27, 2023 | 6:09 pm

UNFI

BMO Capital Markets analyst Kelly Bania reiterated a Market Perform on United Natural Foods, Inc. (UNFI), lowering the price target to $13 from $20. UNFI reported Q4 FY23 sales growth of 2% YoY to $7.417 billion, missing the analyst consensus. Bania sees long-term structural headwinds for UNFI, particularly as the grocery environment becomes more competitive and the company's investments in automation weigh on FCF. The analyst also sees a risk that cross-selling wins were aided by supply chain disruptions, and management visibility remains low.

Portfolio Pulse from Nabaparna Bhattacharya

September 27, 2023 | 6:05 pm

USB

A significant bearish stance has been taken on U.S. Bancorp (NYSE:USB) as evidenced by unusual options activity. The overall sentiment of these big-money traders is split between 45% bullish and 54% bearish. The whales have been targeting a price range from $27.5 to $45.0 for U.S. Bancorp over the last 3 months. The price of USB is currently down -2.0% at $32.36. Analysts from Oppenheimer, Citigroup, Piper Sandler, and HSBC have maintained their ratings on U.S. Bancorp with price targets of $62, $37, $40, and $39 respectively.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 6:01 pm

CATY

In the last quarter, Cathay General (NASDAQ:CATY) received one somewhat bullish rating and three indifferent ratings from analysts. The company's average 12-month price target has increased by 7.95% from $37.75 to $40.75, with a high of $45.00 and a low of $38.00.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 6:01 pm

MTB

M&T Bank (NYSE:MTB) has received five somewhat bullish analyst ratings in the last quarter, with an average price target of $156.6, indicating potential upside from the current price of $123.15. This average price target represents a 0.76% decrease from the previous average price target of $157.80.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 6:00 pm

RNST

Renasant (NASDAQ:RNST) has received indifferent ratings from four analysts in the last quarter. The average 12-month price target for the stock is $31.25, an increase of 0.81% from the previous average price target of $31.00.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 6:00 pm

INZY

Inozyme Pharma (NASDAQ:INZY) has received predominantly bullish ratings from analysts in the last quarter, with 5 out of 6 analysts giving a bullish rating. The average 12-month price target for the stock is $19.33, an increase of 1.74% from the previous average price target of $19.00.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 6:00 pm

NTES

Over the past 10 years, NetEase (NASDAQ:NTES) has outperformed the market by 11.52% on an annualized basis, producing an average annual return of 21.1%. If an investor had bought $100 of NTES stock 10 years ago, it would be worth $677.55 today.

Portfolio Pulse from Benzinga Insights

September 27, 2023 | 6:00 pm